Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patientThe ACTION3 Phase 3 trial explores the efficacy and safety ...
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel ...
These results establish proton therapy as a transforming, safe, and patient-focused solution, poised to redefine the global standard of care for oropharyngeal cancer.
American primary-care doctors can prescribe methadone for pain—but not for addiction. Meanwhile, their counterparts in ...
News-Medical.Net on MSN
A new trial investigates whether the MIND diet can be scaled for obesity management
This study protocol outlines a 12-week randomized trial testing whether a MIND diet intervention is feasible, acceptable, and ...
ACTION3 is a pivotal multicentre, randomised, double-blind, placebo-controlled study of the efficacy and safety of DMX-200 in ...
MedPage Today on MSN
Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer
SAN ANTONIO -- Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune ...
Iain Chapple and Elena Figuero take a deep dive into the evidence supporting the use of adjunctive chemical agents such as ...
Some of our most promising biotechs have taken part in a pre yuletide rush of clinical trial updates – and there is much to ...
Atlantic City, a place of historic mayoral misdeeds, multi-millionaire overreach and chronic unwanted attention, has managed ...
Essilorluxottica (OTC) ($ESLOY) announced an update on their ongoing clinical study. Essilorluxottica is currently conducting a clinical study ...
A large US-based study has found that people with type 2 diabetes taking GLP-1 drugs such as Ozempic may be slightly less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback